Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
VIAVI delivered a significant beat-and-raise quarter driven by 56.9% year-over-year revenue growth, fueled by AI-driven data center demand and the successful integration of Spirent, leading to an accelerated $2 billion revenue run rate target.
Caseys General Stores Chief Merch. Officer Thomas P. Brennan Jr. Sells $2.36M of Stock
Thomas P. Brennan Jr., Chief Merch. Officer, sold 3,000 shares of Caseys General Stores Inc at $779.88 to $799.83 a share (average $786.53) in 2 transactions, worth $2.36M in total on Jun 29, 2026. Shares held after the trade: 11,171 (-15.2%).
Takeda Pharmaceutical Co President, OBU Teresa Marie Bitetti Sells $974K of Stock
Teresa Marie Bitetti, President, OBU, sold 46,609 shares of Takeda Pharmaceutical Co Ltd at $20.89 a share, worth $974K in total on Nov 2, 2026. Shares held after the trade: 214,501 (-17.9%).
Porch Group COO Matthew Neagle Sells $1.17M of Stock
Matthew Neagle, COO, sold 56,250 shares of Porch Group, Inc. at $20.71 to $21.29 a share (average $20.88) in 2 transactions, worth $1.17M in total on Nov 2, 2026. Shares held after the trade: 1,736,756 (-1.0%).
Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.7M of Stock
Nippon Life Insurance Co, 10% Owner, bought 190,251 shares of Corebridge Financial, Inc. at $35.23 a share, worth $6.7M in total on Nov 2, 2026. Shares held after the trade: 132,534,113 (+0.1%).
Warrior Met Coal delivered strong Q3 2026 results with 48% sales volume growth driven by Blue Creek, generating $139 million free cash flow and supporting a $2 per share special dividend despite Mine 7 geological challenges.
Kinetik Holdings reported Q3 2026 financial results with record processed gas volumes of 1.94 Bcf/d and net income of $50.9 million. The company reached a final investment decision on the ECCC Pipeline expansion and expects full-year 2026 Adjusted EBITDA to be at the high end of its $1.04 billion to $1.1 billion guidance range.
“Kinetik delivered another strong quarter with record processed gas volumes underscoring the strength and increasing scale of our business. As our strategic growth projects come online and processed gas volumes continue to increase, our financial performance is increasingly driven by durable, repeatable earnings.”
Jamie Welch, Kinetik’s President & Chief Executive Officer
“The momentum we have built throughout the year has continued into the fourth quarter. Producer activity remains strong, processed gas volumes are tracking toward our approximately 2.2 Bcf/d fourth quarter 2026 target, and margins and costs continue to outperform our internal budget expectations.”
Jamie Welch, Kinetik’s President & Chief Executive Officer
Outset Medical reported total revenue of $33.6 million for the third quarter of 2026, an increase from $29.4 million in the prior year period. The company reduced its quarterly net loss to $14.7 million compared to $17.8 million in Q3 2025, driven by improved gross margins and lower operating expenses.
Medicus Pharma announced that its wholly-owned subsidiary, SkinJect, Inc., has entered into a non-binding letter of intent for a business combination with an undisclosed SPAC. The proposed transaction contemplates a $135 million pre-money enterprise valuation for SkinJect and is expected to close in the first half of 2027, with Medicus seeking to retain majority ownership.
Value
$135M
“We believe this proposed transaction will represent a meaningful step toward executing our strategic mandate to unlock the value of this important clinical-stage asset for our shareholders. The proposed transaction, in addition to establishing an independent public-market platform and access for Skinject, will also allow Medicus to participate in its future growth”
For the three months ended September 30, 2026, McKesson reported revenues of $111.0 billion, a 7.6% increase year-over-year, and net income attributable to the corporation of $1.2 billion. The company's balance sheet shows a significant increase in total assets to $92.3 billion, primarily driven by higher cash and inventory levels, while stockholders' deficit widened to $4.0 billion.
Niagen Bioscience is navigating a transitional 2026 investment year, focusing on new salt forms and pharmaceutical pipelines to offset current revenue declines and ingredient pricing pressure.
Dime Commercial Bancshares Director Basswood Capital Management L.L.C. Sells $2.72M of Stock
Basswood Capital Management L.L.C., Director, sold 63,678 shares of Dime Commercial Bancshares, Inc. at $42.72 a share, worth $2.72M in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 349,794 (-2.6%).
NewLake Capital Partners reported third quarter 2026 financial results with revenue of $12.0 million and net income of $4.2 million. The company strengthened its balance sheet by repaying all outstanding debt, ending the quarter with $17.9 million in cash and no debt. Additionally, the board extended the company's stock repurchase program through December 31, 2028, with $8.2 million remaining in authorization.
“Our third quarter financial results were in line with our expectations, and year to date we collected 99.7% of contractual rent. Notably, we strengthened our balance sheet by repaying $7.6 million of debt, ending the quarter with no debt outstanding and $17.9 million in cash.”
Anthony Coniglio, NewLake’s President and Chief Executive Officer
“With a disciplined focus on property-level cash flow, a debt-free balance sheet and available credit capacity, we believe NewLake is well positioned to pursue growth opportunities as the cannabis regulatory landscape matures.”
Anthony Coniglio, NewLake’s President and Chief Executive Officer
cbdMD M&A Deal with Twinlab Consolidated Holdings, Inc.
cbdMD, Inc. completed the acquisition of the operating assets and brands of Twinlab Consolidated Holdings, including the Twinlab, Reserveage, and Metabolife brands, through a Florida assignment for the benefit of creditors proceeding. The consideration included the assumption of senior secured debt and the issuance of approximately 2.23 million shares of common stock to the secured creditor. The deal diversifies cbdMD's portfolio beyond hemp-derived products into the broader nutritional supplement and wellness market.
Bio Green Med Solution Nasdaq/NYSE Compliance Notice
Bio Green Med Solution received a deficiency notice from Nasdaq on October 29, 2026, because its common stock failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 27, 2027, to regain compliance and is considering a reverse stock split as a potential remedy in connection with its pending business combination with Future NRG Sdn. Bhd.
Nature’s Sunshine Products reported third quarter 2026 net sales of $116.6 million, a 9% decrease compared to the prior year, driven by operational disruptions in China and challenges in its Digital business. GAAP net income fell to $1.9 million, or $0.11 per diluted share, down from $5.3 million in the same period last year.
Term
Q3 2026
“Our third-quarter results were disappointing and fell short of our expectations. We faced several challenges in our business, particularly in China and in our Digital business.”
Ken Romanzi, CEO of Nature’s Sunshine
“While our third quarter performance was far from our expectations, our confidence in the long-term potential of Nature's Sunshine remains strong.”
The filing details Prospect Capital Corp's investment portfolio as of September 30, 2026, highlighting a diverse range of holdings across sectors such as Consumer Finance, Energy, and Structured Finance. Notable investments include significant positions in CP Energy Services, First Tower Finance, and various CLO structured notes.
Amazon Com CEO Worldwide Amazon Stores Douglas J. Herrington Sells $243K of Stock
Douglas J. Herrington, CEO Worldwide Amazon Stores, sold 1,000 shares of Amazon Com Inc at $243.47 a share, worth $243K in total on Nov 2, 2026. Shares held after the trade: 473,681 (-0.2%).
Quoin Pharmaceuticals entered into an at-the-market (ATM) sales agreement with Leerink Partners LLC to sell American Depositary Shares (ADSs) from time to time. Leerink Partners will act as the sales agent and receive a 3.0% commission on gross proceeds from any sales made under the program.
HCI Group delivered record Q3 2026 results with significant operational leverage, record cash flows, and a robust balance sheet, despite navigating multiple hurricane events and a softening insurance market.
Super Group (SGHC) COO Kirsty Farrah Ross Sells $29.3K of Stock
Kirsty Farrah Ross, COO, sold 2,724 shares of Super Group (SGHC) Ltd at $10.74 a share, worth $29.3K in total on Nov 2, 2026. Shares held after the trade: 51,316 (-5.0%).
Navient reported a third-quarter 2026 GAAP net income of $15 million, a significant improvement from a net loss of $86 million in the prior year, driven by $162 million in gains from selling $750 million of Legacy Private Education Loans. However, results were pressured by a $227 million provision for loan losses in the Consumer Lending segment due to elevated delinquency and charge-off forecasts.
Stoneridge reported a net loss of $22.9 million for the third quarter of 2026, compared to a $9.4 million loss in the prior year, primarily driven by higher costs of goods sold and a loss from discontinued operations. Total net sales increased to $155.8 million for the quarter, but the company faced an operating loss of $23.8 million as it navigated the disposal of its Control Devices segment.
Caci International Insider Lisa S. Disbrow Sells $142K of Stock
Lisa S. Disbrow sold 210 shares of Caci International Inc at $678.38 a share, worth $142K in total on Nov 3, 2026. Shares held after the trade: 2,473 (-7.8%).
Western Union reported third-quarter 2026 revenues of $1,009.3 million, a decrease from $1,032.6 million in the prior year period. Net income for the quarter fell to $78.0 million compared to $139.6 million in 2025, driven by higher operating expenses and a decline in operating income from $201.9 million to $130.8 million.
Genco Shipping & Trading reported Q3 2026 net income of $38.0 million and declared a record quarterly dividend of $1.05 per share. The company highlighted its fleet renewal strategy, including the delivery of its third high-specification Capesize vessel of the year, and projected a Q4 2026 dividend exceeding $1.00 per share.
Term
Q3 2026
“The strength of Genco’s Comprehensive Value Strategy was once again evident in the third quarter, as we capitalized on a robust drybulk market to generate strong earnings and dividends for shareholders. Since the inception of our value strategy in 2021, we have taken deliberate steps to transform Genco into a low-leverage, high-dividend company, renewing and investing in our fleet of premium-earning assets, driving industry-low breakeven levels and enhancing our leading commercial platform.”
John C. Wobensmith, Chairman and Chief Executive Officer
Summit Therapeutics Inc. filed a prospectus supplement to its automatic shelf registration statement on Form S-3 for the potential issuance of common stock. The filing includes a legal opinion from Baker & Hostetler LLP regarding the legality of the shares being offered.
Stoneridge reported Q3 2026 adjusted revenue of $180.0 million, a 29.9% increase year-over-year, driven by record sales in MirrorEye and Stoneridge Brazil. Results were impacted by a $24.2 million pre-tax charge related to an adverse arbitration ruling regarding legacy PM sensor warranty claims. The company raised its full-year adjusted sales guidance to $690-$700 million while narrowing adjusted EBITDA expectations to the bottom of its previous range.
Term
Q3 2026
“We delivered another quarter of strong execution, with adjusted sales growth of nearly 30% and adjusted EBITDA growth of more than 40% year over year, despite increasing inflationary pressures and supply chain disruption.”
Natalia Noblet, president and chief executive officer
“We are encouraged by our progress, and our strengthened leadership team remains intensely focused on execution, mitigating inflationary headwinds and delivering results as global vehicle production volumes recover from the cyclical trough.”
Natalia Noblet, president and chief executive officer
Datadog reported strong growth for the third quarter of 2026, with revenue reaching $1.20 billion, a 35% increase year-over-year. The company achieved a significant turnaround in profitability, posting an operating income of $74.7 million compared to an operating loss of $5.8 million in the same period of 2025.